Literature DB >> 23996139

Extracellular L-asparaginase from a protease-deficient Bacillus aryabhattai ITBHU02: purification, biochemical characterization, and evaluation of antineoplastic activity in vitro.

Yogendra Singh1, Ravi Kumar Gundampati, Medicherla V Jagannadham, S K Srivastava.   

Abstract

An extracellular L-asparaginase produced by a protease-deficient isolate, Bacillus aryabhattai ITBHU02, was purified to homogeneity using ammonium sulfate fractionation and subsequent column chromatography on diethylaminoethyl-Sepharose fast flow and Seralose CL-6B. The enzyme was purified 68.9-fold with specific activity of 680.47 U mg(-1). The molecular weight of the purified enzyme was approximately 38.8 kDa on SDS-PAGE and 155 kDa on native PAGE gel as well as gel filtration column revealing that the enzyme was a homotetramer. The optimum activity of purified L-asparaginase was achieved at pH 8.5 and temperature 40 °C. Kinetic studies depicted that the K m, V max, and k cat values of the enzyme were 0.257 mM, 1.537 U μg(-1), and 993.93 s(-1), respectively. Circular dichroism spectroscopy has showed that the enzyme belonged to α + β class of proteins with approximately 74 % α-helices and 12 % β-sheets. BLASTP analysis of N-terminal sequence K-T-I-I-E-A-V-P-E-L-K-K-I-A of purified L-asparaginase had shown maximum similarity with Bacillus megaterium DSM 319. In vitro cytotoxicity assays with HL60 and MOLT-4 cell lines indicated that the L-asparaginase has significant antineoplastic properties.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23996139     DOI: 10.1007/s12010-013-0455-0

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  8 in total

1.  Characterization of novel L-asparaginases having clinically safe profiles from bacteria inhabiting the hemolymph of the crab, Scylla serrata (Forskål, 1775).

Authors:  V P Lailaja; T G Sumithra; K J Reshma; V N Anusree; P V Amala; T G Kishor; N K Sanil
Journal:  Folia Microbiol (Praha)       Date:  2022-02-09       Impact factor: 2.099

2.  Molecular cloning, characterization, and in-silico analysis of l-asparaginase from Himalayan Pseudomonas sp. PCH44.

Authors:  Subhash Kumar; Sanyukta Darnal; Vijeta Patial; Virender Kumar; Vijay Kumar; Sanjay Kumar; Dharam Singh
Journal:  3 Biotech       Date:  2022-07-09       Impact factor: 2.893

3.  Bacillus aryabhattai BA03: a novel approach to the production of natural value-added compounds.

Authors:  Alicia Paz; Julia Carballo; María José Pérez; José Manuel Domínguez
Journal:  World J Microbiol Biotechnol       Date:  2016-08-25       Impact factor: 3.312

4.  Purification and Characterization of Glutaminase Free Asparaginase from Enterobacter cloacae: In-Vitro Evaluation of Cytotoxic Potential against Human Myeloid Leukemia HL-60 Cells.

Authors:  Islam Husain; Anjana Sharma; Suresh Kumar; Fayaz Malik
Journal:  PLoS One       Date:  2016-02-18       Impact factor: 3.240

5.  L-asparaginase production in the pseudomonas pseudoalcaligenes strain JHS-71 isolated from Jooshan Hot-spring.

Authors:  Arastoo Badoei-Dalfard
Journal:  Mol Biol Res Commun       Date:  2016-03

Review 6.  Current applications and different approaches for microbial l-asparaginase production.

Authors:  Jorge Javier Muso Cachumba; Felipe Antonio Fernandes Antunes; Guilherme Fernando Dias Peres; Larissa Pereira Brumano; Júlio César Dos Santos; Silvio Silvério Da Silva
Journal:  Braz J Microbiol       Date:  2016-10-27       Impact factor: 2.476

7.  PBN11-8, a Cytotoxic Polypeptide Purified from Marine Bacillus, Suppresses Invasion and Migration of Human Hepatocellular Carcinoma Cells by Targeting Focal Adhesion Kinase Pathways.

Authors:  Lanhong Zheng; Xiangjie Zhu; Kangli Yang; Meihong Zhu; Ammad Ahmad Farooqi; Daole Kang; Mi Sun; Yixin Xu; Xiukun Lin; Yingang Feng; Fangfang Liang; Fuming Zhang; Robert J Linhardt
Journal:  Polymers (Basel)       Date:  2018-09-19       Impact factor: 4.329

8.  Optimization of Growth Conditions for Purification and Production of L-Asparaginase by Spirulina maxima.

Authors:  Hanaa H Abd El Baky; Gamal S El Baroty
Journal:  Evid Based Complement Alternat Med       Date:  2016-07-25       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.